vs
Side-by-side financial comparison of Cellectis S.A. (CLLS) and FREQUENCY ELECTRONICS INC (FEIM). Click either name above to swap in a different company.
FREQUENCY ELECTRONICS INC is the larger business by last-quarter revenue ($17.1M vs $9.5M, roughly 1.8× Cellectis S.A.). FREQUENCY ELECTRONICS INC runs the higher net margin — 10.5% vs -265.9%, a 276.4% gap on every dollar of revenue. On growth, Cellectis S.A. posted the faster year-over-year revenue change (375.0% vs 8.3%). Cellectis S.A. produced more free cash flow last quarter ($27.6M vs $-1.1M).
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.
Ultra Electronics Holdings is a British defence and security company. It was listed on the London Stock Exchange and was a constituent of the FTSE 250 Index until it was acquired by Cobham, which is itself owned by Advent International.
CLLS vs FEIM — Head-to-Head
Income Statement — Q2 FY2024 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $9.5M | $17.1M |
| Net Profit | $-25.3M | $1.8M |
| Gross Margin | — | 38.2% |
| Operating Margin | -181.1% | 10.0% |
| Net Margin | -265.9% | 10.5% |
| Revenue YoY | 375.0% | 8.3% |
| Net Profit YoY | -51.9% | -32.1% |
| EPS (diluted) | $-0.28 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $17.1M | ||
| Q3 25 | — | $13.8M | ||
| Q2 25 | — | $20.0M | ||
| Q1 25 | — | $18.9M | ||
| Q4 24 | — | $15.8M | ||
| Q3 24 | — | $15.1M | ||
| Q2 24 | $9.5M | $15.6M | ||
| Q1 24 | — | $13.7M |
| Q4 25 | — | $1.8M | ||
| Q3 25 | — | $634.0K | ||
| Q2 25 | — | $3.2M | ||
| Q1 25 | — | $15.4M | ||
| Q4 24 | — | $2.7M | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | $-25.3M | $2.6M | ||
| Q1 24 | — | $130.0K |
| Q4 25 | — | 38.2% | ||
| Q3 25 | — | 36.8% | ||
| Q2 25 | — | 37.5% | ||
| Q1 25 | — | 43.8% | ||
| Q4 24 | — | 48.2% | ||
| Q3 24 | — | 44.4% | ||
| Q2 24 | — | 40.3% | ||
| Q1 24 | — | 22.6% |
| Q4 25 | — | 10.0% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 18.3% | ||
| Q4 24 | — | 16.5% | ||
| Q3 24 | — | 15.7% | ||
| Q2 24 | -181.1% | 16.0% | ||
| Q1 24 | — | -3.4% |
| Q4 25 | — | 10.5% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 81.4% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | — | 16.1% | ||
| Q2 24 | -265.9% | 16.9% | ||
| Q1 24 | — | 0.9% |
| Q4 25 | — | $0.18 | ||
| Q3 25 | — | $0.07 | ||
| Q2 25 | — | $0.33 | ||
| Q1 25 | — | $1.60 | ||
| Q4 24 | — | $0.28 | ||
| Q3 24 | — | $0.25 | ||
| Q2 24 | $-0.28 | $0.28 | ||
| Q1 24 | — | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $149.0M | $3.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $148.6M | $58.5M |
| Total Assets | $407.1M | $92.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $3.0M | ||
| Q3 25 | — | $4.5M | ||
| Q2 25 | — | $4.7M | ||
| Q1 25 | — | $5.5M | ||
| Q4 24 | — | $9.7M | ||
| Q3 24 | — | $16.2M | ||
| Q2 24 | $149.0M | $18.3M | ||
| Q1 24 | — | $11.7M |
| Q4 25 | — | $58.5M | ||
| Q3 25 | — | $56.3M | ||
| Q2 25 | — | $55.6M | ||
| Q1 25 | — | $51.8M | ||
| Q4 24 | — | $36.2M | ||
| Q3 24 | — | $33.2M | ||
| Q2 24 | $148.6M | $39.8M | ||
| Q1 24 | — | $36.7M |
| Q4 25 | — | $92.3M | ||
| Q3 25 | — | $93.2M | ||
| Q2 25 | — | $93.7M | ||
| Q1 25 | — | $86.4M | ||
| Q4 24 | — | $77.8M | ||
| Q3 24 | — | $84.3M | ||
| Q2 24 | $407.1M | $83.3M | ||
| Q1 24 | — | $77.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.9M | $-523.0K |
| Free Cash FlowOCF − Capex | $27.6M | $-1.1M |
| FCF MarginFCF / Revenue | 290.5% | -6.6% |
| Capex IntensityCapex / Revenue | 13.2% | 3.6% |
| Cash ConversionOCF / Net Profit | — | -0.29× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-523.0K | ||
| Q3 25 | — | $1.2M | ||
| Q2 25 | — | $-155.0K | ||
| Q1 25 | — | $-3.6M | ||
| Q4 24 | — | $3.8M | ||
| Q3 24 | — | $-1.5M | ||
| Q2 24 | $28.9M | $7.5M | ||
| Q1 24 | — | $4.2M |
| Q4 25 | — | $-1.1M | ||
| Q3 25 | — | $385.0K | ||
| Q2 25 | — | $-786.0K | ||
| Q1 25 | — | $-4.0M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | — | $-1.8M | ||
| Q2 24 | $27.6M | $6.7M | ||
| Q1 24 | — | $3.9M |
| Q4 25 | — | -6.6% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | -3.9% | ||
| Q1 25 | — | -20.9% | ||
| Q4 24 | — | 20.8% | ||
| Q3 24 | — | -11.8% | ||
| Q2 24 | 290.5% | 42.8% | ||
| Q1 24 | — | 28.4% |
| Q4 25 | — | 3.6% | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | 13.2% | 5.3% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | — | -0.29× | ||
| Q3 25 | — | 1.83× | ||
| Q2 25 | — | -0.05× | ||
| Q1 25 | — | -0.24× | ||
| Q4 24 | — | 1.44× | ||
| Q3 24 | — | -0.60× | ||
| Q2 24 | — | 2.85× | ||
| Q1 24 | — | 32.36× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLLS
Segment breakdown not available.
FEIM
| POC Revenue | $14.8M | 86% |
| POT Revenue | $2.3M | 13% |
